Press release
Vaccine Management Solution Market Is Expected To Progress At A CAGR Of 11.9% by 2032
The vaccine management solution market has emerged as a crucial player in the global healthcare landscape, gaining substantial attention in the wake of the COVID-19 pandemic. With the imperative need for efficient vaccine distribution, inventory management, and tracking, vaccine management solutions have proven their worth. In this comprehensive overview, we will explore the current state of the vaccine management solution market, key factors driving its growth, and recent industry news that highlights the role these solutions play in enhancing public health and immunization efforts.The global vaccine management solution market has reached a valuation of US$ 233 million in 2022 and is expected to progress at a CAGR of 11.9% to reach US$ 721 million by the end of 2032. Deployment of vaccine management solutions accounted for less than 2% share of the global pharmacy management market at the end of 2021. A major driver of the vaccine management solution market expansion is the commitment that numerous countries have made to the Global Vaccine Action Plan (GVAP). The use of a centralized system and a vaccine management solution is likely to aid providers in managing workflow more successfully.
๐๐ผ๐๐ป๐น๐ผ๐ฎ๐ฑ ๐ฎ ๐ฆ๐ฎ๐บ๐ฝ๐น๐ฒ ๐๐ผ๐ฝ๐ ๐ผ๐ณ ๐ง๐ต๐ถ๐ ๐ฅ๐ฒ๐ฝ๐ผ๐ฟ๐:
https://www.factmr.com/connectus/sample?flag=S&rep_id=5466
๐ ๐ฎ๐ฟ๐ธ๐ฒ๐ ๐๐ฎ๐ป๐ฑ๐๐ฐ๐ฎ๐ฝ๐ฒ
The global vaccine management solution market has undergone a significant transformation in recent years, primarily catalyzed by the urgency to distribute COVID-19 vaccines worldwide. As of my last knowledge update in September 2021, this market was valued at approximately $280 million. However, it is important to note that the dynamics of the vaccine management solution market have evolved since then, given the rapid developments in vaccine distribution and administration.
๐๐ฒ๐ ๐๐ฎ๐ฐ๐๐ผ๐ฟ๐ ๐๐ฟ๐ถ๐๐ถ๐ป๐ด ๐๐ฟ๐ผ๐๐๐ต
COVID-19 Pandemic: The COVID-19 pandemic has been a primary driver for the vaccine management solution market. The urgency to vaccinate billions of people globally has accelerated the adoption of these solutions, from tracking vaccine distribution to ensuring equitable access.
Immunization Programs: Immunization campaigns against various diseases are a key driver for vaccine management solutions. Governments and healthcare organizations are increasingly relying on these tools to streamline the logistics of vaccine distribution and record-keeping.
Inventory Management: Vaccine management solutions assist in monitoring vaccine inventories, reducing wastage, and ensuring vaccines are stored and distributed within the recommended temperature range, a critical factor in maintaining vaccine efficacy.
Data Security: The need for secure and compliant data storage and sharing has become paramount, given the sensitive nature of vaccine administration data. Vaccine management solutions are instrumental in maintaining data privacy and integrity.
Telehealth and Remote Vaccination: The advent of telehealth and remote vaccination services has prompted the need for digital tools that can seamlessly integrate with these services. Vaccine management solutions are evolving to accommodate these changing healthcare delivery models.
๐ฆ๐ผ๐บ๐ฒ ๐ผ๐ณ ๐๐ต๐ฒ ๐ธ๐ฒ๐ ๐ฑ๐ฒ๐๐ฒ๐น๐ผ๐ฝ๐บ๐ฒ๐ป๐๐ ๐ฎ๐ฟ๐ฒ :
In 2020, Omnisys announced launching OmniLINK vaccine management solution (VMS) that particularly focuses on pharmacy-administered immunization programs.
In February 2020, Infosys, an Indian multinational information technology company, announced acquiring a Utah-based company named Simplus for US$ 250 million. The acquisition assists the company in providing vaccine management solutions.
๐๐ฒ๐ ๐๐ผ๐บ๐ฝ๐ฎ๐ป๐ถ๐ฒ๐ ๐ฃ๐ฟ๐ผ๐ณ๐ถ๐น๐ฒ๐ฑ
Infosys
Deloitte
Salesforce
Conduent
UL LLC
Sense Corp
Qualtrics
Omnisys
Promero
PreCheck
Epazz
Mazik Global
HealthRX
๐ฅ๐ฒ๐ฐ๐ฒ๐ป๐ ๐๐ป๐ฑ๐๐๐๐ฟ๐ ๐ก๐ฒ๐๐
As of my last knowledge update, here are some significant developments in the vaccine management solution market:
Global Vaccination Campaigns: The deployment of COVID-19 vaccines on a global scale has been a remarkable feat, with vaccine management solutions at the core of the effort. This has brought to light the importance of these solutions in ensuring the equitable distribution of vaccines and tracking of immunization progress.
Digital Vaccine Passports: Many countries have introduced digital vaccine passports or certificates to facilitate international travel. Vaccine management solutions play a pivotal role in generating and verifying these digital documents.
Integration with EHRs: Integration between vaccine management solutions and electronic health records (EHRs) is becoming more seamless. This enables healthcare providers to access a patient's vaccination history and administer vaccines more effectively.
Blockchain for Vaccine Tracking: Blockchain technology is being explored for vaccine tracking and supply chain management. The immutable nature of blockchain ensures the transparency and traceability of vaccine distribution.
Vaccine Mandates: In response to the COVID-19 pandemic, several governments and organizations have introduced vaccine mandates. Vaccine management solutions are essential for tracking and verifying compliance with these mandates.
Supply Chain Resilience: The vaccine management solution market has brought attention to the need for resilient and agile supply chains in healthcare. The ability to respond quickly to disruptions and ensure the continuous flow of vaccines is crucial.
Pharmaceutical Partnerships: Collaboration between vaccine management solution providers and pharmaceutical companies has become more prevalent. This fosters innovation in vaccine management technology and ensures seamless integration with vaccine manufacturers' systems.
๐ฆ๐ฒ๐ด๐บ๐ฒ๐ป๐๐ฎ๐๐ถ๐ผ๐ป ๐ผ๐ณ ๐ฉ๐ฎ๐ฐ๐ฐ๐ถ๐ป๐ฒ ๐ ๐ฎ๐ป๐ฎ๐ด๐ฒ๐บ๐ฒ๐ป๐ ๐ฆ๐ผ๐น๐๐๐ถ๐ผ๐ป ๐๐ป๐ฑ๐๐๐๐ฟ๐
๐๐ ๐๐ผ๐บ๐ฝ๐ผ๐ป๐ฒ๐ป๐ :
Solutions
Inventory Management
Program Management
Clinical V. Management
Data Management
Public Engagement
Organizational Support
Services
Managed Services
Professional Services
๐๐ ๐ ๐ผ๐ฑ๐ฒ๐น :
Platform Solutions
One Point Solutions
๐๐ ๐ฆ๐๐ฏ๐๐ฐ๐ฟ๐ถ๐ฝ๐๐ถ๐ผ๐ป :
New Subscribers
Renew Subscribers
๐๐ ๐๐ป๐ฑ-๐จ๐๐ฒ :
Public
Private
๐๐ ๐ฅ๐ฒ๐ด๐ถ๐ผ๐ป :
North America
Latin America
Europe
East Asia
South Asia & Oceania
Middle East & Africa
๐๐ฒ๐ ๐๐๐๐๐ผ๐บ๐ถ๐๐ฎ๐๐ถ๐ผ๐ป ๐ผ๐ป ๐๐ต๐ถ๐ ๐ฅ๐ฒ๐ฝ๐ผ๐ฟ๐ ๐ณ๐ผ๐ฟ ๐ฆ๐ฝ๐ฒ๐ฐ๐ถ๐ณ๐ถ๐ฐ ๐ฅ๐ฒ๐๐ฒ๐ฎ๐ฟ๐ฐ๐ต ๐ฆ๐ผ๐น๐๐๐ถ๐ผ๐ป๐:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=5466
๐๐ป๐ต๐ฎ๐ป๐ฐ๐ถ๐ป๐ด ๐๐บ๐บ๐๐ป๐ถ๐๐ฎ๐๐ถ๐ผ๐ป ๐๐ณ๐ณ๐ผ๐ฟ๐๐
Vaccine management solutions have proven to be indispensable tools in public health initiatives. From streamlining vaccine distribution to enabling accurate record-keeping, these solutions are the linchpin in global immunization campaigns. The COVID-19 pandemic has underscored their importance, but their value extends beyond this crisis to routine immunization programs.
One of the key areas of innovation is the development of digital vaccine passports or certificates. These documents are essential for verifying an individual's vaccination status, facilitating travel, and gaining access to public venues. Vaccine management solutions are at the forefront of generating and verifying these digital certificates, ensuring their integrity and security.
Additionally, the integration of vaccine management solutions with electronic health records has made vaccine administration more efficient. Healthcare providers can quickly access a patient's vaccination history, make informed decisions, and ensure that individuals are up to date with their immunizations.
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E Mail : sales@factmr.com
About Fact.MR
Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range - from automotive & industry 4.0 to healthcare, technology, chemical and materials, to even the most niche categories.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Vaccine Management Solution Market Is Expected To Progress At A CAGR Of 11.9% by 2032 here
News-ID: 3304563 • Views: โฆ
More Releases from Fact.MR

Bioinformatics Market is Growing at a CAGR of 13.4% by 2034 | Fact.MR Report
The latest report on the Bioinformatics Market, projecting robust growth driven by the increasing demand for genomic research, advancements in artificial intelligence (AI), and the rising adoption of precision medicine. Valued at USD 14.29 billion in 2024, the global market is forecast to expand at a compound annual growth rate (CAGR) of 13.4%, reaching USD 50.25 billion by 2034. This significant growth underscores the critical role of bioinformatics in decodingโฆ

Residential Robotic Vacuum Cleaner Market to Reach USD 11.6 Billion by 2033 | Ke โฆ
Fact.MR today released its latest report on the Residential Robotic Vacuum Cleaner Market, projecting robust growth driven by increasing demand for automation, busy lifestyles, and advancements in smart home technologies. Valued at USD 3.0 billion in 2023, the global market is forecast to expand at a compound annual growth rate (CAGR) of 14.4%, reaching USD 11.6 billion by 2033. This significant growth highlights the rising adoption of robotic vacuum cleanersโฆ

Brain-Computer Interface Market is Estimated to Reach USD 6.5 Billion by 2033
The global brain-computer interface (BCI) market was valued at USD 1.6 billion in 2022 and is projected to reach USD 6.5 billion by 2033, growing at a compound annual growth rate (CAGR) of 13.6% from 2023 to 2033. This expansion reflects the increasing adoption of BCI technologies in medical applications, driven by advancements in neuroscience, AI, and sensor technologies. BCIs enable direct communication between the brain and external devices, offeringโฆ

Orally Disintegrating Tablet Market is Projected to Reach USD 72.68 Billion by 2 โฆ
The global orally disintegrating tablet (ODT) market is valued at USD 24.45 billion in 2024 and is forecasted to expand at a compound annual growth rate (CAGR) of 11.5%, reaching USD 72.68 billion by 2034. This robust growth is driven by the increasing demand for patient-friendly dosage forms, particularly among the elderly, pediatric, and dysphagic populations, who benefit from ODTs' ease of administration without water and rapid dissolution. ODTs enhanceโฆ
More Releases for Vaccine
Adult Vaccines Market By Type (Preventive Vaccine, Therapeutic Vaccine)
Global Adult Vaccines Market 2022 Research Report initially provides a basic overview of the industry that covers definition, applications and manufacturing technology, post which the report explores into the international players in the market.
Download Sample PDF at ย https://www.theinsightpartners.com/sample/TIPRE00007244/?utm_source=OpenPR&utm_medium=10379
Key Players Analysis:
ย AstraZeneca
ย Bharat Biotech
ย Dynavax Technologies Corporation
ย GlaxoSmithKline
ย Johnson & Johnson
ย Merck and Co
ย Novartis
ย Pfizer
ย Sanofi Pasteur
ย Serum Institute of India
The report covers key developments in the Adult Vaccines market as organic and inorganic growth strategies. Various companies are focusingโฆ
Flu Vaccine (Influenza Vaccine) Market: A look into the future of the โUnivers โฆ
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, marketโฆ
Vaccine Market
Rise in the prevalence of infectious diseases, increase in immunization programs across the globe, and surge in R&D activities to develop new vaccine drive the growth of the global vaccine market.
Global Vaccines Market was pegged at $32.46 billion in 2019, and is anticipated to hit $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, topโฆ
US Flu Vaccine [Influenza Vaccine] Market Research Report 2020
DPI Research offers a latest published report on โInfluenza Vaccines in the United States โ Market Size, Trends, Opportunities and Growth Potentialโ delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key US flu vaccines market players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyzeโฆ
Measles Vaccine
Measles Vaccine Market describes its growth, size, share, Forecast and trends to 2025
Measles Vaccine Market Production and Demand Analysis 2019 to 2025
Measles Vaccine Market 2019 Manufacturing Analysis and Development Forecast 2025
Measles Vaccine Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025
Measles Vaccine Market to Insight By 2025: Top Key Vendors
The global Measles Vaccine market is valued at million US$ in 2018 and will reach million US$ by theโฆ
Monovalent vaccine segment to accumulate maximum Paediatric Vaccine Market share
According to a new report published by Future Market Insights titled โPaediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 โ 2026โ, in terms of revenue, the global paediatric vaccine market is expected to increase at 12.2% CAGR during the forecast period 2016-2026. The global paediatric vaccine market is expected to reach US$ 27.97 Bn in 2016.
Paediatric vaccine market is a billion dollar market accounting for a substantial proportionโฆ